# Solitary Thyroid Nodule

> A solitary thyroid nodule (STN) is a single, discrete swelling in the thyroid gland, distinguishable from normal thyroid tissue.

# Causes

1. **Benign (Most Common ~90%)**
   - `Colloid nodule` (hyperplastic nodule in multinodular goiter).
   - `Follicular adenoma` (benign tumor of follicular cells).
   - `Thyroid cyst` (fluid-filled nodule, may be degenerating adenoma).
   - `Thyroiditis` (Hashimoto's, subacute).
   - `Parathyroid adenoma` (may mimic thyroid nodule).
2. **Malignant (~5-10%)**
   - `Papillary thyroid carcinoma` (most common thyroid cancer).
   - `Follicular thyroid carcinoma` (capsular/vascular invasion differentiates it from adenoma).
   - `Medullary thyroid carcinoma` (associated with MEN 2 syndrome).
   - `Anaplastic carcinoma` (rare, aggressive).
   - `Primary thyroid lymphoma` (seen in Hashimoto's thyroiditis).
   - `Metastases` (renal cell carcinoma, breast cancer).

## Investigation

### 1. Laboratory Tests

1. **TSH, T3, T4** (First-line)
   - ↓ TSH → `Toxic adenoma` → Perform **radioisotope scan**.
   - ↑ TSH → `Hashimoto's thyroiditis` or hypothyroidism.
1. **Serum calcitonin**
   - If **medullary thyroid carcinoma (MTC)** suspected.
1. **Anti-TPO, Anti-Tg Antibodies**
   - If `Hashimoto's thyroiditis` suspected.

### 2. Imaging

#### Ultrasound (First-line Imaging Test)

- **Benign Features:**
  - Well-defined, cystic, hyperechoic, comet-tail artifact.
- **Malignant Features:**
  - Hypoechoic, microcalcifications, irregular margins, taller-than-wide shape, vascularity.

#### Radioisotope Scan (Tc-99m or I-123)

- **Only if TSH is low (hyperfunctioning nodule suspected).**
  - **Hot nodule** → Increased uptake → `Toxic adenoma` (low malignancy risk).
  - **Cold nodule** → No uptake → Higher malignancy risk → FNAC needed.

### 3. Fine-Needle Aspiration Cytology (FNAC) (Gold StandarDiagnosis)

- Performed if:
  - Nodule **>1 cm** with suspicious ultrasound features.
  - **Cold nodule** on isotope scan.
  - Any nodule in high-risk patients (history of radiation, family history).
- Classified using **Bethesda system**

<details>
<summary>Bethesda System for Thyroid Cytopathology</summary>

- A standardized reporting system for `fine-needle aspiration cytology (FNAC)` results of thyroid nodules.
- Helps determine the likelihood of malignancy and guide management.
- Does **not** stage cancer but classifies nodules based on cytology.

| Bethesda Category                                                                                        | Risk of Malignancy | Management                                    |
| -------------------------------------------------------------------------------------------------------- | ------------------ | --------------------------------------------- |
| **I. Non-diagnostic/Unsatisfactory**                                                                     | 1-4%               | Repeat FNAC.                                  |
| **II. Benign** (e.g., colloid nodule, Hashimoto's)                                                       | < 3%               | Follow-up.                                    |
| **III. Atypia of undetermined significance (AUS)/Follicular lesion of undetermined significance (FLUS)** | 6-18%              | Repeat FNAC, molecular testing, or lobectomy. |
| **IV. Follicular neoplasm/Suspicious for follicular neoplasm**                                           | 10-40%             | Lobectomy (histopathology needed).            |
| **V. Suspicious for malignancy**                                                                         | 45-75%             | Lobectomy or total thyroidectomy.             |
| **VI. Malignant (e.g., papillary, medullary carcinoma)**                                                 | 97-99%             | Total thyroidectomy ± lymph node dissection.  |

</details>

<details>
<summary>TNM Staging (Used Only for Confirmed Thyroid Cancer)</summary>

- Used for **staging malignant thyroid nodules** after histopathological diagnosis.
- Determines **prognosis** and guides further treatment.

1. **T (Tumor Size & Local Spread)**
   - T1: ≤2 cm, confined to thyroid.
   - T2: 2-4 cm, confined to thyroid.
   - T3: >4 cm or minimal extrathyroidal extension.
   - T4: Tumor invades surrounding structures (e.g., trachea, esophagus).
1. **N (Nodal Involvement)**
   - N0: No lymph node metastasis.
   - N1a: Central (level VI) lymph node involvement.
   - N1b: Lateral or mediastinal lymph nodes involved.
1. **M (Distant Metastasis)**
   - M0: No distant metastasis.
   - M1: Distant metastasis (lung, bone, etc.).

</details>

## Management of Solitary Thyroid Nodule

### 1. Benign Nodule (Bethesda II - Colloid Nodule, Cyst, Thyroiditis)

- Small, asymptomatic → Observation:
  - Serial ultrasound every 6-12 months.
- Large, symptomatic → Surgery (`lobectomy` or `thyroidectomy`).

### 2. Indeterminate/Follicular Neoplasm (Bethesda III, IV)

- `Lobectomy` (to differentiate follicular adenoma vs carcinoma).

### 3. Malignant or Suspicious Nodule (Bethesda V, VI)

- `Total thyroidectomy` ± `Lymph node dissection`.
- `Post-op Radioactive Iodine (RAI) Therapy` for **papillary** or **follicular carcinoma**.
- `TSH Suppression Therapy` (`Levothyroxine`) to prevent recurrence.

### 4. Toxic (Hyperfunctioning) Nodule (↓ TSH, Hot on Scan)

- `Radioactive Iodine` (Preferred) or `Surgery`.
